We studied the effect of chlorpromazine on fluid accumulation caused by purified heat-stable enterotoxin (ST) from enterotoxigenic Escherichia coli in suckling mice. We found that chlorpromazine inactivated ST itself in vitro, but did not inhibit the activity of ST in the intestines.
MATERIALS AND METHODS Preparation of ST. ST was isolated and purified from the culture supernatant of E. coli 53402 A-1, an ST-producing strain isolated from a human patient, as described previously (12) . The purification procedure consisted of protamine sulfate treatment, ultrafiltration through an Amicon PM-10 membrane, diethylaminoethyl-cellulose column chromatography, hydroxyapatite column chromatography, Bio-Gel P-10 gel filtration, 90% ethanol extraction, and preparative polyacrylamide gel disc electrophoresis. The minimum effective dose of the purified ST used in this work was about 2.5 ng in the suckling mouse assay. The minimal amount of ST giving an FA ratio (see below) of more than 0.09 after 4 h was tentatively designated as 1 mouse unit.
Assay of ST in suckling mice. ST activity was assayed in suckling mice as described previously (11) . Breeding colonies of white mice (Nippon Clea, Osaka, Japan) were established in our laboratory, and suckling mice of 2 to 3 days old were used in the assays. Doses of 0.1 ml of samples were administered by a gastric tube to mice, with about 0.001% Evans blue as a marker. Four hours after the administration of the sample, animals were killed with chloroform. After confirming the presence of the dye in the intestinal lumen, we removed the entire intestine. The FA ratio of each animal was calculated as the ratio of the weight of the entire intestine to that of the rest of the body.
Other materials. Powdered CPZ hydrochloride from Yoshitomi Pharmaceutical Industry Ltd., Osaka, Japan, was used. It was dissolved in distilled water since it did not dissolve completely in either phosphate-buffered saline (pH 7.0) or phosphate buffer (pH 7.0). In some experiments, commercially available CPZ hydrochloride solution for injection (Contomin; Yoshitomi) was also used. Essentially the same results were obtained with the two preparations.
Purified cholera enterotoxin (7) was kindly provided by N. Ohtomo, Chemo-Sero-Therapeutic Research Institute, Kumamoto, Japan.
RESULTS
We examined the effect of CPZ on FA induced by purified ST in suckling mice. When CPZ was administered 30 min before ST administration, significant inhibition of FA by CPZ was observed, whereas no appreciable inhibition was observed when CPZ was administered either simultaneously with ST or 30 min afterwards (Table 1) . Although the former result is similar to that ofAbbey and Knoop (1), the latter results are inconsistent with their results. Thus, the effect of preincubation of ST with CPZ on FA by ST was examined. When a mixture of ST and CPZ was administered without preincubation (that is, immediately after mixing), no appreciable inhibition of FA by CPZ was observed (Fig.  1) . On the other hand, when the mixture was preincubated at 370C for 30 min, FA by ST was significantly decreased by CPZ, the effect of 2 mouse units of ST being completely prevented by 50 ,ug of CPZ.
Decrease in the FA ratio was dependent on the duration of the preincubation of ST with CPZ. Even preincubation for only a few minutes (Fig. 2) . Thus, all the above observations were made at 4 h after ST administration. On the other hand, when CPZ was administered, maximal FA was observed about 5 to 6 h after ST administration (Fig. 2) . The FA ratio of mice 4 h after treatment with ST alone and that of mice 6 h after treatment with both ST and CPZ were quite similar ( The recent report of Abbey and Knoop (1) that CPZ also inhibits E. coli ST prompted us to study the effect of CPZ on ST activity, since it has been reported that ST stimulates guanylate cyclase, but not adenylate cyclase (3) . The experimental data reported in this paper are not consistent with those of Abbey and Knoop (1).
Although there is a possibility that the conflicting results are in part due to differences in the ST preparations used in the studies of Abbey and Knoop (1) and in those used in ours, we conclude that CPZ inactivates ST itself, but does not inhibit FA caused by ST in vivo.
The in vitro inactivation of ST by CPZ is shown in Fig. 1 and Table 2 . Figure 1 confirmed the inhibitory effect of CPZ on FA by ST reported by Abbey and Knoop (1). However, this figure and the data in Table 2 led us to conclude that CPZ inactivates ST. Abbey and Knoop (1) also reported that CPZ inhibits ST activity when administered before or after ST. The results in Fig. 2 show that there was a considerable delay in the response of suckling mice to ST when CPZ was administered. This might be because CPZ reduces peristaltic movement.
Powdered CPZ hydrochloride did not dissolve completely in either phosphate-buffered saline (pH 7.0) or phosphate buffer (pH 7.0), but was dissolved in distilled water. Since ST is unstable at pH 2.0 or less (12) , the pH of the CPZ solution in distilled water was measured and confirmed to be 5.01.
L6nnroth et al. (6) reported that CPZ was effective in the treatment of diarrhea in piglets infected with enterotoxigenic E. coli producing both LT and ST. If ST were produced in the intestine of infected animals, the data of Lonnroth et al. are not consistent with our conclusion. But these workers reported that no ST could be detected in the small intestinal fluid of the diarrhea-infected piglets, although LT was detected.
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Thus, in these piglets, LT, but not ST, was responsible for the diarrhea.
